BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11221700)

  • 1. [Progress of medicine threatened by drug resistance].
    Sante; 2000; 10(5):363-4. PubMed ID: 11221700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effective control of drug-resistant TB: listening to other voices.
    Portero JL; Rubio M
    PLoS Med; 2006 Dec; 3(12):e542. PubMed ID: 17194207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Managements of tuberculosis complicated with HIV infection and AIDS].
    Xiao H; He G
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):659-62. PubMed ID: 11225028
    [No Abstract]   [Full Text] [Related]  

  • 5. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tuberculosis: antibiotic resistances, more than ever a menace].
    Nau JY
    Rev Med Suisse; 2012 Sep; 8(353):1746-7. PubMed ID: 23029990
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of drug resistance on the global tuberculosis epidemic.
    Schluger NW
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of patients with resistant bacterial infections.
    Rahal JJ
    Bull N Y Acad Med; 1987 Apr; 63(3):318-29. PubMed ID: 3300830
    [No Abstract]   [Full Text] [Related]  

  • 9. DOTS plus strategy in resource-poor countries.
    Davies PD
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):843-4. PubMed ID: 10488896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concerning tuberculosis].
    Sante; 2000; 10(5):362-3. PubMed ID: 11221699
    [No Abstract]   [Full Text] [Related]  

  • 11. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?
    Lobato MN; Jereb JA; Castro KG
    Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Lamivudine resistance reported in acute HIV infection.
    Newsline People AIDS Coalit N Y; 1999; ():33. PubMed ID: 11367346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine-resistant hepatitis B detected in HIV-infected patients.
    Newsline People AIDS Coalit N Y; 1999 Jan; ():36. PubMed ID: 11367194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries.
    Amaral L; Viveiros M; Kristiansen JE
    Trop Med Int Health; 2001 Dec; 6(12):1016-22. PubMed ID: 11737839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant tuberculosis: desperate measures?
    Cullinan T
    Lancet; 2001 Apr; 357(9262):1124. PubMed ID: 11297986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.